DIRECT DIGITAL HOLDINGS IN-A (DRCT) Fundamental Analysis & Valuation
NASDAQ:DRCT • US25461T2042
Current stock price
0.8744 USD
-0.06 (-6.02%)
At close:
0.92 USD
+0.05 (+5.22%)
Pre-Market:
This DRCT fundamental analysis includes valuation metrics, fair value assessment, financial health analysis, profitability trends, growth metrics and dividend sustainability analysis.
1. DRCT Profitability Analysis
1.1 Basic Checks
- DRCT had negative earnings in the past year.
- DRCT had a negative operating cash flow in the past year.
- DRCT had negative earnings in 4 of the past 5 years.
- In multiple years DRCT reported negative operating cash flow during the last 5 years.
1.2 Ratios
- DRCT has a worse Return On Assets (-42.00%) than 78.26% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -42% | ||
| ROE | N/A | ||
| ROIC | N/A |
ROA(3y)-6.66%
ROA(5y)-5.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
- With a Gross Margin value of 31.43%, DRCT perfoms like the industry average, outperforming 41.30% of the companies in the same industry.
- In the last couple of years the Gross Margin of DRCT has declined.
- The Profit Margin and Operating Margin are not available for DRCT so they could not be analyzed.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 31.43% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.71%
GM growth 5YN/A
2. DRCT Health Analysis
2.1 Basic Checks
- DRCT does not have a ROIC to compare to the WACC, probably because it is not profitable.
- Compared to 1 year ago, DRCT has more shares outstanding
- DRCT has a worse debt/assets ratio than last year.
2.2 Solvency
- Based on the Altman-Z score of -2.16, we must say that DRCT is in the distress zone and has some risk of bankruptcy.
- The Altman-Z score of DRCT (-2.16) is worse than 75.00% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Altman-Z | -2.16 |
ROIC/WACCN/A
WACC10.72%
2.3 Liquidity
- DRCT has a Current Ratio of 0.37. This is a bad value and indicates that DRCT is not financially healthy enough and could expect problems in meeting its short term obligations.
- DRCT has a worse Current ratio (0.37) than 83.70% of its industry peers.
- DRCT has a Quick Ratio of 0.37. This is a bad value and indicates that DRCT is not financially healthy enough and could expect problems in meeting its short term obligations.
- DRCT's Quick ratio of 0.37 is on the low side compared to the rest of the industry. DRCT is outperformed by 83.70% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.37 | ||
| Quick Ratio | 0.37 |
3. DRCT Growth Analysis
3.1 Past
- DRCT shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -1762.87%.
- Looking at the last year, DRCT shows a very negative growth in Revenue. The Revenue has decreased by -62.46% in the last year.
- Measured over the past years, DRCT shows a quite strong growth in Revenue. The Revenue has been growing by 17.76% on average per year.
EPS 1Y (TTM)-1762.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-534.62%
Revenue 1Y (TTM)-62.46%
Revenue growth 3Y17.76%
Revenue growth 5YN/A
Sales Q2Q%-12.02%
3.2 Future
- DRCT is expected to show a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 34.33% yearly.
- Based on estimates for the next years, DRCT will show a very negative growth in Revenue. The Revenue will decrease by -10.39% on average per year.
EPS Next Y-1659.23%
EPS Next 2Y34.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year-49.24%
Revenue Next 2Y-10.39%
Revenue Next 3YN/A
Revenue Next 5YN/A
3.3 Evolution
- The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. DRCT Valuation Analysis
4.1 Price/Earnings Ratio
- DRCT reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
- Also next year DRCT is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | N/A |
4.3 Compensation for Growth
- A more expensive valuation may be justified as DRCT's earnings are expected to grow with 34.33% in the coming years.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y34.33%
EPS Next 3YN/A
5. DRCT Dividend Analysis
5.1 Amount
- DRCT does not give a dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
DRCT Fundamentals: All Metrics, Ratios and Statistics
0.8744
-0.06 (-6.02%)
Chartmill FA Rating
GICS SectorCommunication Services
GICS IndustryGroupMedia & Entertainment
GICS IndustryMedia
Earnings (Last)11-06 2025-11-06/amc
Earnings (Next)03-31 2026-03-31/amc
Inst Owners0.68%
Inst Owner Change-99.99%
Ins Owners0.86%
Ins Owner Change0%
Market Cap2.08M
Revenue(TTM)35.37M
Net Income(TTM)-9.46M
Analysts80
Price Target112.2 (12731.66%)
Short Float %2.87%
Short Ratio0.01
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0% |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-707.56%
Min EPS beat(2)-1468.63%
Max EPS beat(2)53.51%
EPS beat(4)1
Avg EPS beat(4)-2044.59%
Min EPS beat(4)-6762.75%
Max EPS beat(4)53.51%
EPS beat(8)1
Avg EPS beat(8)-1272.49%
EPS beat(12)2
Avg EPS beat(12)-831.71%
EPS beat(16)5
Avg EPS beat(16)-613.34%
Revenue beat(2)0
Avg Revenue beat(2)-40.4%
Min Revenue beat(2)-64.81%
Max Revenue beat(2)-15.98%
Revenue beat(4)0
Avg Revenue beat(4)-32.8%
Min Revenue beat(4)-64.81%
Max Revenue beat(4)-14.88%
Revenue beat(8)0
Avg Revenue beat(8)-38.81%
Revenue beat(12)4
Avg Revenue beat(12)-16.24%
Revenue beat(16)6
Avg Revenue beat(16)-7.36%
PT rev (1m)0%
PT rev (3m)5400%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-5400%
EPS NY rev (1m)0%
EPS NY rev (3m)-5400%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)-20.72%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.06 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | N/A | ||
| P/tB | N/A | ||
| EV/EBITDA | N/A |
EPS(TTM)-45.51
EYN/A
EPS(NY)-0.56
Fwd EYN/A
FCF(TTM)-3.62
FCFYN/A
OCF(TTM)-3.61
OCFYN/A
SpS14.86
BVpS-0.49
TBVpS-6.7
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -42% | ||
| ROE | N/A | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 31.43% | ||
| FCFM | N/A |
ROA(3y)-6.66%
ROA(5y)-5.43%
ROE(3y)N/A
ROE(5y)N/A
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-16.71%
GM growth 5YN/A
F-Score3
Asset Turnover1.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | N/A | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | N/A | ||
| Cap/Depr | 1.7% | ||
| Cap/Sales | 0.11% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 0.37 | ||
| Quick Ratio | 0.37 | ||
| Altman-Z | -2.16 |
F-Score3
WACC10.72%
ROIC/WACCN/A
Cap/Depr(3y)14.5%
Cap/Depr(5y)N/A
Cap/Sales(3y)0.3%
Cap/Sales(5y)N/A
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)-1762.87%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%-534.62%
EPS Next Y-1659.23%
EPS Next 2Y34.33%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)-62.46%
Revenue growth 3Y17.76%
Revenue growth 5YN/A
Sales Q2Q%-12.02%
Revenue Next Year-49.24%
Revenue Next 2Y-10.39%
Revenue Next 3YN/A
Revenue Next 5YN/A
EBIT growth 1Y13.66%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year50.13%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-435.56%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-352.53%
OCF growth 3YN/A
OCF growth 5YN/A
DIRECT DIGITAL HOLDINGS IN-A / DRCT Fundamental Analysis FAQ
What is the fundamental rating for DRCT stock?
ChartMill assigns a fundamental rating of 1 / 10 to DRCT.
What is the valuation status of DIRECT DIGITAL HOLDINGS IN-A (DRCT) stock?
ChartMill assigns a valuation rating of 1 / 10 to DIRECT DIGITAL HOLDINGS IN-A (DRCT). This can be considered as Overvalued.
What is the profitability of DRCT stock?
DIRECT DIGITAL HOLDINGS IN-A (DRCT) has a profitability rating of 1 / 10.
Can you provide the financial health for DRCT stock?
The financial health rating of DIRECT DIGITAL HOLDINGS IN-A (DRCT) is 0 / 10.